Short report: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis

49Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

Melioidosis is an infectious disease endemic to northern Australia and Southeast Asia. In response to clinical confusion regarding the appropriate dose of amoxicillin-clavulanate, we have developed guidelines for the appropriate dosing of this second-line agent. For eradication therapy for melioidosis, we recommend 20/5 mg/kg orally, three times daily. Copyright © 2008 by The American Society of Tropical Medicine and Hygiene.

Cite

CITATION STYLE

APA

Cheng, A. C., Chierakul, W., Chaowagul, W., Chetchotisakd, P., Limmathurotsakul, D., Dance, D. A. B., … Currie, B. J. (2008). Short report: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. American Journal of Tropical Medicine and Hygiene, 78(2), 208–209. https://doi.org/10.4269/ajtmh.2008.78.208

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free